Health
Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2 – News-Medical.Net
Researchers have shown that using reliable antibody tests in conjunction is an effective way to estimate seroprevalence in low prevalence settings.
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, in December 2019. It has since spread to 192 countries and territories, infecting over 100 million individuals and claiming over 2.2 million lives. To date, Japan has reported 391,945 cases and 5,833 deaths.
A team of researchers in Japan have developed commercially available antibody tests to estimate the seroprevalence of SARS-CoV-2 infection…
-
General23 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Business23 hours agoWhy this ASX 200 stock could deliver a 30% return
-
Noosa News24 hours agoMan charged with murder after alleged assault leaves 40-year-old dead in Hervey Bay
-
Noosa News24 hours agoQueensland Police Pipes and Drums to perform with World-Renowned Royal Edinburgh Military Tattoo